BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
6/25/2021 9:46:23 AM | Browse: 593 | Download: 1140
 |
Received |
|
2021-02-16 11:38 |
|
Peer-Review Started |
|
2021-02-16 11:43 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-28 01:15 |
|
Revised |
|
2021-04-11 21:21 |
|
Second Decision |
|
2021-05-22 14:44 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2021-05-22 15:17 |
|
Articles in Press |
|
2021-05-22 15:17 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2021-06-19 09:02 |
|
Publish the Manuscript Online |
|
2021-06-25 09:46 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Minireviews |
| Article Title |
Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Michail Galanopoulos, Aris Doukatas, Filippos Gkeros, Nikos Viazis and Christos Liatsos |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Michail Galanopoulos, FEBG, MD, PhD, Doctor, Doctor, Department of Gastroenterology, Addenbrooke’s Hospital, Hills Road, Cambridge CB2 0QQ, United Kingdom. galanopoulosdr@gmail.com |
| Key Words |
Pancreatic cancer; Gene therapy; Viral vectors; Gene editing; miRNA; siRNA; Oncolytic virotherapy |
| Core Tip |
Pancreatic cancer still remains one of the leading causes of cancer deaths worldwide. While there are various therapeutic approaches established, there is still a crucial need for improvement of conventional treatments and establishment of novel therapies to increase efficacy. This review exhibits an overview of the most promising present and future prospects regarding gene therapy which offers a new favorable opportunity not only to tackle with an inoperable pancreatic cancer, but also, to treat effectively its early stages. |
| Publish Date |
2021-06-25 09:46 |
| Citation |
Galanopoulos M, Doukatas A, Gkeros F, Viazis N, Liatsos C. Room for improvement in the treatment of pancreatic cancer: Novel opportunities from gene targeted therapy. World J Gastroenterol 2021; 27(24): 3568-3580 |
| URL |
https://www.wjgnet.com/1007-9327/full/v27/i24/3568.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v27.i24.3568 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
